TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 DKK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
21,210,834
|
18,707,753
|
17,799,017 |
| Financial expenses |
24,994
|
158,115
|
7,512 |
| Earnings before taxes |
3,804,263
|
3,518,688
|
2,925,912 |
| EBITDA |
4,842,299
|
4,724,544
|
3,869,731 |
| Total assets |
31,479,494
|
28,873,657
|
25,384,615 |
| Current assets |
22,514,652
|
20,234,043
|
17,889,080 |
| Current liabilities |
2,967,038
|
2,913,285
|
2,301,336 |
| Equity capital |
26,912,705
|
24,533,041
|
21,654,462 |
| - share capital |
892
|
894
|
743 |
| Employees (average) |
9,734
|
8,336
|
8,141 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
85.5%
|
85.0%
|
85.3% |
| Turnover per employee |
2,179
|
2,244
|
2,186 |
| Profit as a percentage of turnover |
17.9%
|
18.8%
|
16.4% |
| Return on assets (ROA) |
12.2%
|
12.7%
|
11.6% |
| Current ratio |
758.8%
|
694.5%
|
777.3% |
| Return on equity (ROE) |
14.1%
|
14.3%
|
13.5% |
| Change turnover |
4,018,421
|
1,245,650
|
655,857 |
| Change turnover % |
23%
|
7%
|
4% |
| Chg. No. of employees |
1,398
|
195
|
233 |
| Chg. No. of employees % |
17%
|
2%
|
3% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.